Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors
Kelsey E. Hirotsu, Madeleine Scott, César Márquez, Anhthy T. Tran, Kerri E. Rieger, Roberto A. Novoa, William H. Robinson, Bernice Y. Kwong, Lisa C. Zaba
Topics & Concepts
MedicineImmune systemAdverse effectImmune checkpointImmunologyOncologyImmunotherapyInternal medicineCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways